Nuclear Receptor Coactivator 3 (NCOA3) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Nuclear Receptor Coactivator 3 (NCOA3) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Nuclear Receptor Coactivator 3 (NCOA3) |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.01 mg, 0.02 mg, 0.05 mg |
| Concentration | 200ug/ml |
| Applications | Western Blot (WB), Immunocytochemistry (ICC), Immunohistochemistry (IHC) Formalin/Paraffin, ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | The antibody is a rabbit polyclonal antibody raised against NCOA3. It has beenselected for its ability to recognize NCOA3 in immunohistochemical staining andwestern blotting. |
| Immunogen | Immunogen: Recombinant NCOA3 (Gly1023~Ala1304) expressed in E Coli. Conjugated Antibody: The APC conjugated antibody version of this item is also available as catalog #MBS2075523 |
| Other Names | [nuclear receptor coactivator 3 isoform d; Nuclear receptor coactivator 3; nuclear receptor coactivator 3; nuclear receptor coactivator 3; ACTR; Amplified in breast cancer 1 protein; AIB-1; CBP-interacting protein; pCIP; Class E basic helix-loop-helix protein 42; bHLHe42; Receptor-associated coactivator 3; RAC-3; Steroid receptor coactivator protein 3; SRC-3; Thyroid hormone receptor activator molecule 1; TRAM-1] |
| Gene, Accession # | [NCOA3], Gene ID: 8202, NCBI: NP_001167559.1, UniProt: Q9Y6Q9 |
| Catalog # | MBS2027621 |
| Price | $110, $130, $175 |
| Order / More Info | Nuclear Receptor Coactivator 3 (NCOA3) Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies